The Head Start Effect: Will Acute and Delayed Postoperative Mortality Lead to Improved Survival with Stereotactic Body Radiation Therapy for Operable Stage I Non–Small-Cell Lung Cancer?-Reference-Cited by-同舟云学术

The Head Start Effect: Will Acute and Delayed Postoperative Mortality Lead to Improved Survival with Stereotactic Body Radiation Therapy for Operable Stage I Non–Small-Cell Lung Cancer?

Published:2017-05-20 Issue:15 Volume:35 Page:1749-1751
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Rusthoven Chad G.¹,Palma David A.¹,Senan Suresh¹,Kavanagh Brian D.¹

Affiliation:

1. Chad G. Rusthoven, University of Colorado School of Medicine, Aurora, CO; David A. Palma, London Health Sciences Centre, London, Ontario, Canada; Suresh Senan, VU University Medical Center, Amsterdam, Netherlands; and Brian D. Kavanagh, University of Colorado School of Medicine, Aurora, CO

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.72.0003

Reference18 articles.

1. Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non–Small-Cell Lung Cancer: A Competing Risks Analysis

2. Surgical treatment of lung cancer: Predicting postoperative morbidity in the elderly population

3. Postoperative Mortality Is an Inadequate Quality Indicator for Lung Cancer Resection

4. Pulmonary Function Tests as a Predictor of Quantitative and Qualitative Outcomes After Thoracic Surgery for Lung Cancer

5. Impact of Teaching Facility Status and High-Volume Centers on Outcomes for Lung Cancer Resection: An Examination of 13,469 Surgical Patients

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists;Translational Lung Cancer Research;2021-04

2. The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts;Radiotherapy and Oncology;2020-04

3. International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?;ERJ Open Research;2020-01

4. Helping patients with lung cancer choose between surgery or stereotactic body radiotherapy: the importance of the patient experience;Journal of Thoracic Disease;2019-11

5. Questionnaire survey comparing surgery and stereotactic body radiotherapy for lung cancer: lessons from patients with experience of both modalities;Journal of Thoracic Disease;2019-06